G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer

BACKGROUND: Eukaryotic histone methyltransferases 2 (EHMT2 or G9A) has been regarded as a potential target for non-small cell lung cancer (NSCLC) therapy. This study investigated the regulatory roles of G9A in tumorigenesis and stemness in NSCLC. We isolated and enriched tumor-initiating cells (TIC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Pangeni, Rajendra P., Yang, Lu, Zhang, Keqiang, Wang, Jinhui, Li, Wendong, Guo, Chao, Yun, Xinwei, Sun, Ting, Wang, Jami, Raz, Dan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302379/
https://www.ncbi.nlm.nih.gov/pubmed/32552834
http://dx.doi.org/10.1186/s13148-020-00879-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302379/
https://www.ncbi.nlm.nih.gov/pubmed/32552834
http://dx.doi.org/10.1186/s13148-020-00879-5

Ejemplares similares